Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LP5G
|
||||
Former ID |
DNC012550
|
||||
Drug Name |
2-Phenyl-1H-imidazo[4,5-c]quinolin-4-ylamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [530590] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H12N4
|
||||
Canonical SMILES |
C1=CC=C(C=C1)C2=NC3=C(N2)C(=NC4=CC=CC=C43)N
|
||||
InChI |
1S/C16H12N4/c17-15-14-13(11-8-4-5-9-12(11)18-15)19-16(20-14)10-6-2-1-3-7-10/h1-9H,(H2,17,18)(H,19,20)
|
||||
InChIKey |
IBRIUJBAFMFSDF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2a receptor | Target Info | Inhibitor | [530590] | |
Adenosine A1 receptor | Target Info | Inhibitor | [530590] | ||
Adenosine A2b receptor | Target Info | Inhibitor | [530590] | ||
KEGG Pathway | Rap1 signaling pathway | ||||
Calcium signaling pathway | |||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
Vascular smooth muscle contraction | |||||
Parkinson's disease | |||||
Alcoholismhsa04022:cGMP-PKG signaling pathway | |||||
Sphingolipid signaling pathway | |||||
Morphine addictionhsa04015:Rap1 signaling pathway | |||||
Alcoholism | |||||
Pathway Interaction Database | HIF-2-alpha transcription factor networkcmyb_pathway:C-MYB transcription factor network | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.